NA
ABBV icon

Nautilus Advisors’s AbbVie ABBV Stock Holding History

Nautilus Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86M Sell
7,491
-910
-11% -$196K 1.1% 20
2026
Q1 		$1.83M Sell
8,401
-147
-2% -$32.6K 1.25% 20
2025
Q4 		$1.95M Sell
8,548
-96
-1% -$21.9K 1.28% 18
2025
Q3 		$2M Buy
8,644
+317
+4% +$64.6K 1.35% 16
2025
Q2 		$1.55M Buy
8,327
+1,065
+15% +$198K 1.13% 20
2025
Q1 		$1.52M Buy
7,262
+2
+0% +$389 1.26% 15
2024
Q4 		$1.29M Buy
+7,260
New +$1.33M 1.03% 22

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Nautilus Advisors's ABBV Position: Q2 2026 in Review

Nautilus Advisors reduced its AbbVie (ABBV) stake by 11% in Q2 2026, selling an estimated $196K and leaving 7,491 shares worth $1.86M. The position accounts for 1.1% of the portfolio, ranked #20.

Nautilus Advisors first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $2M in Q3 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Nautilus Advisors held 7,491 shares of AbbVie worth $1.86M as of Q2 2026.
  • Nautilus Advisors sold 910 AbbVie shares in Q2 2026, an estimated $196K.
  • AbbVie made up 1.1% of Nautilus Advisors's portfolio in Q2 2026, its #20 holding.
  • Nautilus Advisors first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Nautilus Advisors's AbbVie position peaked at $2M in Q3 2025.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Nautilus Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.